The Role of NO/sGC/cGMP/PKG Signaling Pathway in Regulation of Platelet Function
Circulating blood platelets are controlled by stimulatory and inhibitory factors, and a tightly regulated equilibrium between these two opposing processes is essential for normal platelet and vascular function. NO/cGMP/ Protein Kinase G (PKG) pathways play a highly significant role in platelet inhib...
Main Author: | Stepan Gambaryan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/22/3704 |
Similar Items
-
Cyclic GMP and PKG Signaling in Heart Failure
by: Genri Numata, et al.
Published: (2022-04-01) -
cGMP-Dependent Protein Kinase Inhibitors in Health and Disease
by: Jens Schlossmann, et al.
Published: (2013-02-01) -
Potential and limitations of PKA/ PKG inhibitors for platelet studies
by: Valentina Shpakova, et al.
Published: (2022-08-01) -
Programmed Non-Apoptotic Cell Death in Hereditary Retinal Degeneration: Crosstalk between cGMP-Dependent Pathways and PARthanatos?
by: Jie Yan, et al.
Published: (2021-09-01) -
cGMP Signaling in Photoreceptor Degeneration
by: Shujuan Li, et al.
Published: (2023-07-01)